Atropine eye drops for watery eyes
Part of Eyes & vision clinical trials.
This study tests whether atropine eye drops can reduce excessive tearing (watery eyes) caused by various reasons. If you have watery eyes that bother you daily, these drops might help by decreasing tear production.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have watery eyes (epiphora) that need wiping or dabbing at least twice a day
- You have adequate vision (20/200 or better) in at least one eye
- You are willing to put drops in your eyes once nightly for 7 days and attend study visits
- You do not have significant dry eye, active eye infection, or glaucoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial studies whether numbing eye drops (proparacaine 0.5%) can reduce pain during a procedure called probing and irrigation of the tear drainage system. If you need this test for ongoing watery eyes, the trial may help make the procedure more comfortable.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Epiphora trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.